A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)
I8B-MC-ITSI - ClinicalTrials.gov - NCT03433677
The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulinlispro with an insulin pump in adults with type 1 diabetes.
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Type 1 DiabetesWhat the trial is testing?
Insulin lispro, LY900014Could I receive a Placebo?
NoEnrollment Goal
49Trial Dates
Feb 21, 2018 - Sep 4, 2018How long will I be in the trial?
Your participation could last about 19 weeks and include up to 10 visits to the study center.Trial Phase
IIILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo